{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:39:48Z","timestamp":1772159988113,"version":"3.50.1"},"reference-count":29,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":690,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Andrologia"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1111\/and.12178","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T07:43:15Z","timestamp":1381736595000},"page":"936-942","source":"Crossref","is-referenced-by-count":36,"title":["Combination of intralesional verapamil and oral antioxidants for Peyronie's disease: a prospective, randomised controlled study"],"prefix":"10.1155","volume":"46","author":[{"given":"V.","family":"Favilla","sequence":"first","affiliation":[{"name":"Department of Urology; University of Catania; Catania Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. I.","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Urology; University of Catania; Catania Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Privitera","sequence":"additional","affiliation":[{"name":"Department of Urology; University of Catania; Catania Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Castelli","sequence":"additional","affiliation":[{"name":"Department of Urology; University of Catania; Catania Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Madonia","sequence":"additional","affiliation":[{"name":"Department of Urology; University of Sassari; Sassari Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"La Vignera","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Systemic Diseases; Section of Endocrinology, Andrology and Internal Medicine; University of Catania; Catania Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Condorelli","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Systemic Diseases; Section of Endocrinology, Andrology and Internal Medicine; University of Catania; Catania Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. E.","family":"Calogero","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Systemic Diseases; Section of Endocrinology, Andrology and Internal Medicine; University of Catania; Catania Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. P.","family":"Farina","sequence":"additional","affiliation":[{"name":"Department of Urology; University of Sassari; Sassari Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Cimino","sequence":"additional","affiliation":[{"name":"Department of Urology; University of Catania; Catania Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Morgia","sequence":"additional","affiliation":[{"name":"Department of Urology; University of Catania; Catania Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,10,11]]},"reference":[{"issue":"Suppl 3","key":"10.1111\/and.12178-BIB0001|and12178-cit-0001","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/sj.ijir.3900558","article-title":"Inhibition of Peyronie's plaque fibroblast proliferation by biologic agents","volume":"12","author":"Anderson","year":"2000","journal-title":"Int J Impot Res"},{"key":"10.1111\/and.12178-BIB0002|and12178-cit-0002","doi-asserted-by":"crossref","first-page":"632959","DOI":"10.1155\/2012\/632959","article-title":"Polyphenols: key issues involved in chemoprevention of prostate cancer","volume":"2012","author":"Cimino","year":"2012","journal-title":"Oxid Med Cell Longev"},{"key":"10.1111\/and.12178-BIB0003|and12178-cit-0003","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0022-5347(01)64223-X","article-title":"Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression","volume":"158","author":"El-Sakka","year":"1997","journal-title":"J Urol"},{"key":"10.1111\/and.12178-BIB0004|and12178-cit-0004","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1464-410X.2010.09459.x","article-title":"Relationship between lower urinary tract symptoms and serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia","volume":"106","author":"Favilla","year":"2010","journal-title":"BJU Int"},{"key":"10.1111\/and.12178-BIB0005|and12178-cit-0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/aja.2012.9","article-title":"Penile reconstruction","volume":"15","author":"Garaffa","year":"2013","journal-title":"Asian J Androl"},{"key":"10.1111\/and.12178-BIB0006|and12178-cit-0006","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/01.ju.0000053800.62741.fe","article-title":"Peyronie's disease: a review","volume":"169","author":"Gholami","year":"2003","journal-title":"J Urol"},{"key":"10.1111\/and.12178-BIB0007|and12178-cit-0007","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2012.05.040","article-title":"EAU guidelines on penile curvature","volume":"62","author":"Hatzimouratidis","year":"2012","journal-title":"Eur Urol"},{"key":"10.1111\/and.12178-BIB0008|and12178-cit-0008","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0022-5347(05)64578-8","article-title":"A retrospective review of 307 men with Peyronie's disease","volume":"168","author":"Kadioglu","year":"2002","journal-title":"J Urol"},{"key":"10.1111\/and.12178-BIB0009|and12178-cit-0009","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000280897","article-title":"Classification of congenital and acquired penile deviation","volume":"38","author":"Kelami","year":"1983","journal-title":"Urol Int"},{"key":"10.1111\/and.12178-BIB0010|and12178-cit-0010","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1743-6109.2007.00537.x","article-title":"A Survey of primary-care physicians and urologists regarding Peyronie's disease","volume":"4","author":"LaRochelle","year":"2007","journal-title":"J Sex Med"},{"key":"10.1111\/and.12178-BIB0011|and12178-cit-0011","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0022-5347(05)64691-5","article-title":"Experience with intraplaque injection of verapamil for Peyronie's disease","volume":"168","author":"Levine","year":"2002","journal-title":"J Urol"},{"key":"10.1111\/and.12178-BIB0012|and12178-cit-0012","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1743-6109.2010.02003.x","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its death receptor (DR5) in Peyronie's disease. A biomolecular study of apoptosis activation","volume":"8","author":"Loreto","year":"2011","journal-title":"J Sex Med"},{"key":"10.1111\/and.12178-BIB0013|and12178-cit-0013","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1590\/S1677-5538.IBJU.2013.02.10","article-title":"Effects of Serenoa repens, selenium and lycopene (Profluss(R)) on chronic inflammation associated with benign prostatic hyperplasia: results of \u201cFLOG\u201d (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study","volume":"39","author":"Morgia","year":"2013","journal-title":"Int Braz J Urol"},{"key":"10.1111\/and.12178-BIB0014|and12178-cit-0014","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.ijir.3900874","article-title":"Peyronie's disease cell culture models: phenotypic, genotypic and functional analyses","volume":"14","author":"Mulhall","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1111\/and.12178-BIB0015|and12178-cit-0015","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","article-title":"Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening","volume":"171","author":"Mulhall","year":"2004","journal-title":"J Urol"},{"key":"10.1111\/and.12178-BIB0016|and12178-cit-0016","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1743-6109.2008.01081.x","article-title":"Peyronie's disease intervention trials: methodological challenges and issues","volume":"6","author":"Muller","year":"2009","journal-title":"J Sex Med"},{"key":"10.1111\/and.12178-BIB0017|and12178-cit-0017","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1743-6109.2007.00692.x","article-title":"A brief historical survey of \u201cPeyronie's disease\u201d","volume":"5","author":"Musitelli","year":"2008","journal-title":"J Sex Med"},{"key":"10.1111\/and.12178-BIB0018|and12178-cit-0018","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.mrfmmm.2004.01.015","article-title":"Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription","volume":"551","author":"O'Leary","year":"2004","journal-title":"Mutat Res"},{"key":"10.1111\/and.12178-BIB0019|and12178-cit-0019","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/187152812798889321","article-title":"Inflammatory mechanisms and oxidative stress in Peyronie's disease: therapeutic \u201crationale\u201d and related emerging treatment strategies","volume":"11","author":"Paulis","year":"2012","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1111\/and.12178-BIB0020|and12178-cit-0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/187152812798889321","article-title":"Peironimev-plus(R) in the treatment of Chronic Inflammation of Tunica Albuginea (Peyronie's Disease). Results of a controlled study","volume":"11","author":"Paulis","year":"2012a","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1111\/and.12178-BIB0021|and12178-cit-0021","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2605.2011.01219.x","article-title":"Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: a study of 151 cases","volume":"35","author":"Paulis","year":"2012b","journal-title":"Int J Androl"},{"key":"10.1111\/and.12178-BIB0022|and12178-cit-0022","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.2047-2927.2012.00007.x","article-title":"Efficacy of vitamin E in the conservative treatment of Peyronie's disease: legend or reality? A controlled study of 70 cases","volume":"1","author":"Paulis","year":"2013","journal-title":"Andrology"},{"key":"10.1111\/and.12178-BIB0023|and12178-cit-0023","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1073\/pnas.93.11.5478","article-title":"Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix","volume":"93","author":"Roth","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/and.12178-BIB0024|and12178-cit-0024","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/sj.ijir.3901185","article-title":"Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study","volume":"16","author":"Safarinejad","year":"2004","journal-title":"Int J Impot Res"},{"key":"10.1111\/and.12178-BIB0025|and12178-cit-0025","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1743-6109.2011.02509.x","article-title":"Simultaneous penile lengthening and penile prosthesis implantation in patients with Peyronie's disease, refractory erectile dysfunction, and severe penile shortening","volume":"9","author":"Sansalone","year":"2012","journal-title":"J Sex Med"},{"key":"10.1111\/and.12178-BIB0026|and12178-cit-0026","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","article-title":"The prevalence of Peyronie's disease: results of a large survey","volume":"88","author":"Schwarzer","year":"2001","journal-title":"BJU Int"},{"key":"10.1111\/and.12178-BIB0027|and12178-cit-0027","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2741\/e369","article-title":"Dietary patterns and prostatic diseases","volume":"4","author":"Sebastiano","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1111\/and.12178-BIB0028|and12178-cit-0028","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.ijir.3900863","article-title":"Epidemiology of Peyronie's disease","volume":"14","author":"Sommer","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1111\/and.12178-BIB0029|and12178-cit-0029","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s003450100209","article-title":"Management of Peyronie's disease-a review","volume":"19","author":"Tunuguntla","year":"2001","journal-title":"World J Urol"}],"container-title":["Andrologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fand.12178","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/and.12178\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T07:35:32Z","timestamp":1671521732000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/and.12178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,11]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,10]]}},"URL":"https:\/\/doi.org\/10.1111\/and.12178","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726748011.793523270","asserted-by":"object"}]},"ISSN":["0303-4569"],"issn-type":[{"value":"0303-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10,11]]}}}